Schedule 13d

Filed by: ADVOCAT INC
Subject Company: ADVOCAT, INC.
Filed as of Date: 10/09/2009
View Original Filing on Edgar's
OMB APPROVAL
OMB Number: 3235-0145
Expires: December 31, 2005
Estimated average burden
hours per response. . . 11


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
SCHEDULE 13D
 
Under the Securities Exchange Act of 1934
(Amendment No. 6)*
 
Advocat Inc.
(Name of Issuer)

Common Stock
(Title of Class of Securities)

007586100
(CUSIP Number)

Amy Wang, Esq.
Bristol Capital Advisors, LLC
6353 W. Sunset Boulevard, Suite 4006, Hollywood, CA 90028
(323) 960-3800
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)

October 8, 2009
(Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. [   ]
 
Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.
 
* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
 
The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
 
 
 
 

 
CUSIP No. 007586100
  
 
 
1
NAME OF REPORTING PERSONS. I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (entities only).
 
  Bristol Investment Fund, Ltd.
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a)  o
(b)  o
 
3
SEC USE ONLY
 
4
SOURCE OF FUNDS (See Instructions)
Cash
 
5
CHECK BOX OF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
Cayman Islands
 
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING
PERSON WITH
7
SOLE VOTING POWER
230,998
 
8
SHARED VOTING POWER
 
 
9
SOLE DISPOSITIVE POWER
230,998
 
10
SHARED DISPOSITIVE POWER
 
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
230,998
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
4.07%
 
14
TYPE OF REPORTING PERSON (See Instructions)
CO
 
 
 
2
 
 
The following constitutes Amendment No. 6 ("Amendment No. 6") to the Schedule 13D filed by the undersigned.  This Amendment No. 6 amends the Schedule 13D as specifically set forth

 
Item 5(a) is hereby amended and restated as follows:
 
Item 5.
Interest in Securities of the Issuer
 
 
(a)
As of the date of the filing of this Amendment No. 6 to Schedule 13D, Bristol owns 230,998 Shares, which represents approximately 4.07% of the Shares outstanding, based upon 5,675,987 Shares outstanding as of August 3, 2009 as reported in the Issuer’s quarterly report on Form 10Q, as filed with the Securities and Exchange Commission on August 6, 2009.
 
 
Signature
 
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
 
Dated:  October 9, 2009

BRISTOL INVESTMENT FUND, LTD.


By: /s/ Paul Kessler
 

 
 3